InsidersTradesSigma
Follow the Nexalis Therapeutics Ltd stock price and the full insider trade history of the company, a listed equity based in Australia. Shares trade on the AU market, under the oversight of ASX. Operating in the Health Care sector, Nexalis Therapeutics Ltd has recorded 4 reports. Market capitalisation: €2.8m. The latest transaction was reported on 30 July 2026 (Change in Substantial Holding). Among the most active insiders: NFPFRN (if applicable). Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Nexalis Therapeutics Ltd es una empresa centrada en el desarrollo de tratamientos innovadores en el sector sanitario y farmacéutico. Cotiza en el mercado XASX.